Abiopharma

New Form 8-K - PROTHENA CORP PUBLIC LTD CO Filed: 2025-06-18 AccNo: 0001193125-25-142725 Size: 147 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers